NEW YORK, April 28, 2020 /PRNewswire/ -- Chardan
Healthcare Acquisition 2 Corp. (NYSE American: CHAQ.U, the
"Company") announced today that it closed its initial public
offering of 8,500,000 units at $10.00
per unit. The underwriters have been granted a 45-day option to
purchase up to an additional 1,275,000 units offered by the Company
to cover over-allotments, if any.
The units began trading on the NYSE American ("NYSE") under the
ticker symbol "CHAQ.U" beginning April 24,
2020. Each unit consists of one share of common stock and
one warrant to purchase one-half of one share of common stock at an
exercise price of $11.50 per whole
share. Once the securities comprising the units begin separate
trading, the common stock and warrants are expected to be listed on
the NYSE under the symbols "CHAQ" and "CHAQ.WS" respectively.
Chardan acted as sole book running manager in the offering.
A registration statement relating to these securities was
declared effective by the Securities and Exchange Commission on
April 23, 2020. The offering was made
only by means of a prospectus, copies of which may be obtained by
contacting Chardan Capital Markets, LLC, 17 State Street, 21st
floor, New York, New York 10004.
Copies of the registration statement can be accessed through the
SEC's website at www.sec.gov.
This press release shall not constitute an offer to sell or a
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction.
About Chardan Healthcare Acquisition 2 Corp.
Chardan Healthcare Acquisition 2 Corp. is a blank check company
formed for the purpose of effecting a merger, share exchange, asset
acquisition, share purchase, reorganization or similar business
combination with one or more businesses. The Company's efforts to
identify a prospective target business will not be limited to a
particular industry or geographic region, although the Company
intends to focus its search on a target businesses operating in
North America in the healthcare
industry.
Forward Looking Statements
This press release includes forward-looking statements that
involve risks and uncertainties. Forward looking statements are
statements that are not historical facts. Such forward-looking
statements, including the successful consummation of the Company's
initial public offering, are subject to risks and uncertainties,
which could cause actual results to differ from the forward looking
statements. The Company expressly disclaims any obligations or
undertaking to release publicly any updates or revisions to any
forward-looking statements contained herein to reflect any change
in the Company's expectations with respect thereto or any change in
events, conditions or circumstances on which any statement is
based.
Contact:
Chardan Healthcare Acquisition 2 Corp.
Jonas Grossman
President and CEO
17 State Street, 21st Floor, New York, NY 10004
(646) 465-9090
info@chardanspac.com
View original
content:http://www.prnewswire.com/news-releases/chardan-healthcare-acquisition-2-corp-announces-closing-of-85-million-initial-public-offering-301048794.html
SOURCE Chardan Capital Markets, LLC